DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42(NASDAQ:DHCNI) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to DHCNI. DHCNI was compared to 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of DHCNI have multiple concerns. DHCNI is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

DHCNI had negative earnings in the past year.

DHCNI had a positive operating cash flow in the past year.

In the past 5 years DHCNI reported 4 times negative net income.

The reported operating cash flow has been mixed in the past 5 years: DHCNI reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -7.29%, DHCNI is not doing good in the industry: 92.06% of the companies in the same industry are doing better.

The Return On Equity of DHCNI (-18.81%) is worse than 88.10% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.29%
ROE	-18.81%
ROIC	N/A

ROA(3y)-1.01%

ROA(5y)-1.3%

ROE(3y)-2.2%

ROE(5y)-3.08%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 17.10%, DHCNI is doing worse than 96.03% of the companies in the same industry.

In the last couple of years the Gross Margin of DHCNI has declined.

The Profit Margin and Operating Margin are not available for DHCNI so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	17.1%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-11.61%

GM growth 5Y-22.42%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for DHCNI has been increased compared to 1 year ago.

Compared to 5 years ago, DHCNI has more shares outstanding

Compared to 1 year ago, DHCNI has a worse debt to assets ratio.

2.2 Solvency

DHCNI has an Altman-Z score of 0.26. This is a bad value and indicates that DHCNI is not financially healthy and even has some risk of bankruptcy.

DHCNI has a Altman-Z score of 0.26. This is in the lower half of the industry: DHCNI underperforms 69.05% of its industry peers.

A Debt/Equity ratio of 1.44 is on the high side and indicates that DHCNI has dependencies on debt financing.

DHCNI's Debt to Equity ratio of 1.44 is on the low side compared to the rest of the industry. DHCNI is outperformed by 61.11% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.44
Debt/FCF	N/A
Altman-Z	0.26

ROIC/WACCN/A

WACC7.56%

2.3 Liquidity

DHCNI has a Current Ratio of 5.85. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.

DHCNI has a better Current ratio (5.85) than 95.24% of its industry peers.

DHCNI has a Quick Ratio of 5.85. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.

DHCNI has a Quick ratio of 5.85. This is amongst the best in the industry. DHCNI outperforms 95.24% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	5.85
Quick Ratio	5.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for DHCNI have decreased strongly by -47.23% in the last year.

DHCNI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.62%.

The Revenue has been growing slightly by 4.77% on average over the past years.

EPS 1Y (TTM)-47.23%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-33.33%

Revenue 1Y (TTM)6.62%

Revenue growth 3Y-4.75%

Revenue growth 5Y4.77%

Sales Q2Q%4.8%

3.2 Future

Based on estimates for the next years, DHCNI will show a small growth in Earnings Per Share. The EPS will grow by 5.26% on average per year.

DHCNI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.77% yearly.

EPS Next Y-61.26%

EPS Next 2Y-0.46%

EPS Next 3Y5.26%

EPS Next 5YN/A

Revenue Next Year5.41%

Revenue Next 2Y4.93%

Revenue Next 3Y5.77%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

DHCNI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHCNI. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DHCNI is valued expensively inside the industry as 93.65% of the companies are valued cheaper.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	28.44

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-0.46%

EPS Next 3Y5.26%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

DHCNI has a Yearly Dividend Yield of 1.45%.

With a Dividend Yield of 1.45, DHCNI pays less dividend than the industry average, which is at 18.48. 90.48% of the companies listed in the same industry pay a better dividend than DHCNI!

DHCNI's Dividend Yield is slightly below the S&P500 average, which is at 2.29.

		Industry Rank	Sector Rank
Dividend Yield	1.45%

5.2 History

The dividend of DHCNI decreases each year by -51.94%.

DHCNI has been paying a dividend for over 5 years, so it has already some track record.

DHCNI has not decreased its dividend in the last 3 years.

Dividend Growth(5Y)-51.94%

Div Incr Years0

Div Non Decr Years3

5.3 Sustainability

DHCNI has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-2.5%

EPS Next 2Y-0.46%

EPS Next 3Y5.26%

More info and screens

Find the best dividend stocks

Show peers with best dividend

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (2/21/2025, 8:13:54 PM)

14.68

+0.04 (+0.27%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)11-04 2024-11-04/amc

Earnings (Next)02-25 2025-02-25/amc

Inst Owners74.05%

Inst Owner ChangeN/A

Ins Owners0.35%

Ins Owner ChangeN/A

Market Cap3.54B

Analysts44.44

Price Target23.62 (60.9%)

Short Float %0%

Short Ratio0.21

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.45%

Yearly Dividend0.04

Dividend Growth(5Y)-51.94%

DP-2.5%

Div Incr Years0

Div Non Decr Years3

Ex-Date01-15 2025-01-15 (0.3515625)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)41.93%

Min EPS beat(2)-23.76%

Max EPS beat(2)107.62%

EPS beat(4)1

Avg EPS beat(4)-3.44%

Min EPS beat(4)-70.3%

Max EPS beat(4)107.62%

EPS beat(8)3

Avg EPS beat(8)9.18%

EPS beat(12)3

Avg EPS beat(12)-12.53%

EPS beat(16)5

Avg EPS beat(16)-7.46%

Revenue beat(2)0

Avg Revenue beat(2)-1.81%

Min Revenue beat(2)-2.43%

Max Revenue beat(2)-1.19%

Revenue beat(4)0

Avg Revenue beat(4)-1.35%

Min Revenue beat(4)-2.43%

Max Revenue beat(4)-0.84%

Revenue beat(8)3

Avg Revenue beat(8)-0.62%

Revenue beat(12)3

Avg Revenue beat(12)-1.06%

Revenue beat(16)3

Avg Revenue beat(16)-1.67%

PT rev (1m)0%

PT rev (3m)14.8%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)0.44%

Revenue NQ rev (3m)-0.9%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.46%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.4
P/FCF	N/A
P/OCF	40.8
P/B	1.73
P/tB	1.73
EV/EBITDA	28.44

EPS(TTM)-1.12

EYN/A

EPS(NY)-0.93

Fwd EYN/A

FCF(TTM)-0.48

FCFYN/A

OCF(TTM)0.36

OCFY2.45%

SpS6.12

BVpS8.49

TBVpS8.49

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.29%
ROE	-18.81%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	17.1%
FCFM	N/A

ROA(3y)-1.01%

ROA(5y)-1.3%

ROE(3y)-2.2%

ROE(5y)-3.08%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-11.61%

GM growth 5Y-22.42%

F-Score6

Asset Turnover0.28

Health

		Industry Rank	Sector Rank
Debt/Equity	1.44
Debt/FCF	N/A
Debt/EBITDA	13.46
Cap/Depr	69.24%
Cap/Sales	13.64%
Interest Coverage	N/A
Cash Conversion	39.68%
Profit Quality	N/A
Current Ratio	5.85
Quick Ratio	5.85
Altman-Z	0.26

F-Score6

WACC7.56%

ROIC/WACCN/A

Cap/Depr(3y)107.73%

Cap/Depr(5y)97.46%

Cap/Sales(3y)20.76%

Cap/Sales(5y)20.01%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-47.23%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-33.33%

EPS Next Y-61.26%

EPS Next 2Y-0.46%

EPS Next 3Y5.26%

EPS Next 5YN/A

Revenue 1Y (TTM)6.62%

Revenue growth 3Y-4.75%

Revenue growth 5Y4.77%

Sales Q2Q%4.8%

Revenue Next Year5.41%

Revenue Next 2Y4.93%

Revenue Next 3Y5.77%

Revenue Next 5YN/A

EBIT growth 1Y-20.72%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year378.31%

EBIT Next 3Y75.54%

EBIT Next 5YN/A

FCF growth 1Y74.65%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y199.71%

OCF growth 3Y-59.56%

OCF growth 5Y-51.55%

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens